Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Fair Value Adjustment of Warrants

1.5 / 5 stars · 24/82 Roast Me

AIM IMMUNOTECH INC. Fair Value Adjustment of Warrants

AIM IMMUNOTECH INC. (AIM) reported Fair Value Adjustment of Warrants of $468.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-07

  • AIM IMMUNOTECH INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was $0.00.
  • AIM IMMUNOTECH INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was $468.00K.
  • AIM IMMUNOTECH INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was $942.00K.
  • AIM IMMUNOTECH INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$670.00K.
  • AIM IMMUNOTECH INC. fair value adjustment of warrants for fiscal 2025 was $272.00K, a 40.61% decline from fiscal 2024.
  • AIM IMMUNOTECH INC. fair value adjustment of warrants for fiscal 2024 was $458.00K.
  • AIM IMMUNOTECH INC. fair value adjustment of warrants for fiscal 2022 was -$35.00K.
  • AIM IMMUNOTECH INC. fair value adjustment of warrants for fiscal 2021 was -$145.00K, a 217.89% decline from fiscal 2020.
Period endFair Value Adjustment of Warrants 3 monthFair Value Adjustment of Warrants 6 monthFair Value Adjustment of Warrants 9 monthFair Value Adjustment of Warrants 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$468.00K
10-Q · filed 2026-08-07
$1.41M
derived: sum of 3 quarters · filed 2026-08-07
$740.00K
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$468.00K
10-Q · filed 2026-05-15
$1.41M
derived: sum of 2 quarters · filed 2026-05-15
$740.00K
derived: sum of 3 quarters · filed 2026-05-15
2025-12-31$942.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$272.00K
derived: sum of 2 quarters · filed 2026-03-27
$272.00K
10-K · filed 2026-03-27
2025-09-30-$670.00K
10-Q · filed 2025-11-17
-$670.00K
10-Q · filed 2025-11-17
2024-12-31$458.00K
10-K · filed 2026-03-27
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$1.00K
derived: sum of 2 quarters · filed 2024-04-01
-$4.00K
derived: sum of 3 quarters · filed 2024-04-01
-$35.00K
10-K · filed 2024-04-01
2022-09-30-$1.00K
10-Q · filed 2023-11-14
-$4.00K
derived: sum of 2 quarters · filed 2023-11-14
-$35.00K
10-Q · filed 2023-11-14
-$158.00K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$3.00K
10-Q · filed 2023-08-14
-$34.00K
10-Q · filed 2023-08-14
-$157.00K
derived: sum of 3 quarters · filed 2023-08-14
-$208.00K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$31.00K
10-Q · filed 2023-05-15
-$154.00K
derived: sum of 2 quarters · filed 2023-05-15
-$205.00K
derived: sum of 3 quarters · filed 2023-05-15
-$212.00K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$123.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$174.00K
derived: sum of 2 quarters · filed 2023-03-31
-$181.00K
derived: sum of 3 quarters · filed 2023-03-31
-$145.00K
10-K · filed 2023-03-31
2021-09-30-$51.00K
10-Q · filed 2022-11-14
-$58.00K
derived: sum of 2 quarters · filed 2022-11-14
-$22.00K
10-Q · filed 2022-11-14
-$18.00K
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$7.00K
10-Q · filed 2022-08-15
$29.00K
10-Q · filed 2022-08-15
$33.00K
derived: sum of 3 quarters · filed 2022-08-15
$2.00K
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$37.00K
10-Q · filed 2022-05-13
$40.00K
derived: sum of 2 quarters · filed 2022-05-13
$9.00K
derived: sum of 3 quarters · filed 2022-05-13
-$22.00K
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$3.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
-$28.00K
derived: sum of 2 quarters · filed 2022-03-31
-$59.00K
derived: sum of 3 quarters · filed 2022-03-31
$123.00K
10-K · filed 2022-03-31
2020-09-30-$31.00K
10-Q · filed 2021-11-15
-$62.00K
derived: sum of 2 quarters · filed 2021-11-15
$120.00K
10-Q · filed 2021-11-15
$95.00K
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$31.00K
10-Q · filed 2021-08-16
$150.00K
10-Q · filed 2021-08-16
$126.00K
derived: sum of 3 quarters · filed 2021-08-16
-$320.00K
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31$182.00K
10-Q · filed 2021-05-17
$157.00K
derived: sum of 2 quarters · filed 2021-05-17
-$289.00K
derived: sum of 3 quarters · filed 2021-05-17
-$1.37M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$25.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$471.00K
derived: sum of 2 quarters · filed 2021-03-31
-$1.56M
derived: sum of 3 quarters · filed 2021-03-31
-$1.51M
10-K · filed 2021-03-31
2019-09-30-$446.00K
10-Q · filed 2020-11-12
-$1.53M
derived: sum of 2 quarters · filed 2020-11-12
-$1.49M
10-Q · filed 2020-11-12
-$1.82M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$1.08M
10-Q · filed 2020-08-14
-$1.04M
10-Q · filed 2020-08-14
-$1.38M
derived: sum of 3 quarters · filed 2020-08-14
-$2.08M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$45.00K
10-Q · filed 2020-05-14
-$294.00K
derived: sum of 2 quarters · filed 2020-05-14
-$990.00K
derived: sum of 3 quarters · filed 2020-05-14
-$1.35M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31-$339.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
-$1.03M
derived: sum of 2 quarters · filed 2020-03-30
-$1.40M
derived: sum of 3 quarters · filed 2020-03-30
-$1.17M
10-K · filed 2020-03-30
2018-09-30-$696.00K
10-Q · filed 2019-11-14
-$1.06M
derived: sum of 2 quarters · filed 2019-11-14
-$826.00K
10-Q · filed 2019-11-14
-$883.00K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$362.00K
10-Q · filed 2019-08-14
-$131.00K
10-Q · filed 2019-08-14
-$187.00K
derived: sum of 3 quarters · filed 2019-08-14
-$1.63M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$231.00K
10-Q · filed 2019-05-15
$175.00K
derived: sum of 2 quarters · filed 2019-05-15
-$1.26M
derived: sum of 3 quarters · filed 2019-05-15
-$1.79M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31-$56.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$1.49M
derived: sum of 2 quarters · filed 2019-04-01
-$2.02M
derived: sum of 3 quarters · filed 2019-04-01
-$2.42M
10-K · filed 2019-04-01
2017-09-30-$1.44M
10-Q · filed 2018-11-14
-$1.97M
derived: sum of 2 quarters · filed 2018-11-14
-$2.36M
10-Q · filed 2018-11-14
-$3.93M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$529.00K
10-Q · filed 2018-08-14
-$923.00K
10-Q · filed 2018-08-14
-$2.50M
derived: sum of 3 quarters · filed 2018-08-14
-$2.60M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31-$393.00K
10-Q · filed 2018-05-15
-$1.97M
derived: sum of 2 quarters · filed 2018-05-15
-$2.07M
derived: sum of 3 quarters · filed 2018-05-15
2016-12-31-$1.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30
-$1.68M
derived: sum of 2 quarters · filed 2018-03-30
-$1.68M
10-K · filed 2018-03-30
2016-09-30-$103.00K
10-Q · filed 2017-11-14
-$103.00K
10-Q · filed 2017-11-14
2015-09-30$0.00
10-Q · filed 2015-11-16
$0.00
derived: sum of 2 quarters · filed 2015-11-16
$0.00
10-Q · filed 2015-11-16
2015-06-30$0.00
10-Q · filed 2015-08-12
$0.00
10-Q · filed 2015-08-12
2014-12-31-$13.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31
-$13.00K
derived: sum of 2 quarters · filed 2017-03-31
-$14.00K
derived: sum of 3 quarters · filed 2017-03-31
-$14.00K
10-K · filed 2017-03-31
2014-09-30$0.00
10-Q · filed 2015-11-16
-$1.00K
derived: sum of 2 quarters · filed 2015-11-16
-$1.00K
10-Q · filed 2015-11-16
2014-06-30-$1.00K
10-Q · filed 2015-08-12
-$1.00K
10-Q · filed 2015-08-12
2013-12-31-$281.00K
10-K · filed 2016-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B